WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001036486) SCFV ANTIBODIES AGAINST DISEASE ASSOCIATED MOLECULES
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2001/036486 International Application No.: PCT/GB2000/004317
Publication Date: 25.05.2001 International Filing Date: 13.11.2000
Chapter 2 Demand Filed: 19.04.2001
IPC:
C07K 16/28 (2006.01)
Applicants: KINGSMAN, Alan[GB/GB]; GB (UsOnly)
KINGSMAN, Susan, Mary[GB/GB]; GB (UsOnly)
BEBBINGTON, Christopher, Robert[GB/US]; US (UsOnly)
CARROLL, Miles, William[GB/GB]; GB (UsOnly)
ELLARD, Fiona, Margaret[GB/GB]; GB (UsOnly)
MYERS, Kevin, Alan[GB/GB]; GB (UsOnly)
OXFORD BIOMEDICA (UK) LIMITED[GB/GB]; Medawar Center Robert Robinson Avenue The Oxford Science Park Oxford OX4 4GA, GB (AllExceptUS)
Inventors: KINGSMAN, Alan; GB
KINGSMAN, Susan, Mary; GB
BEBBINGTON, Christopher, Robert; US
CARROLL, Miles, William; GB
ELLARD, Fiona, Margaret; GB
MYERS, Kevin, Alan; GB
Agent: HARDING, Charles, Thomas ; D. Young & Co. 21 New Fetter Lane London EC4A 1DA, GB
Priority Data:
0003527.915.02.2000GB
0005071.602.03.2000GB
PCT/GB99/0385918.11.1999GB
Title (EN) SCFV ANTIBODIES AGAINST DISEASE ASSOCIATED MOLECULES
(FR) ANTICORPS
Abstract:
(EN) The use of an ScFv Ab (ScFv Ab) capable of recognising a disease associated molecule (DAM) in the manufacture of a medicament for the prevention and/or treatment of a disease condition associated with a DAM is described. The ScFv Ab has therapeutic, diagnostic and prognostic applications.
(FR) L'invention concerne l'utilisation d'un anticorps ScFv Ab, capable de reconnaître une molécule associée à une maladie (DAM), dans la préparation d'un médicament destiné à prévenir et/ou traiter un état de maladie associé à une DAM. L'anticorps ScFv Ab est utilisé dans des applications thérapeutiques, diagnostiques et pronostiques.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW
African Regional Intellectual Property Organization (ARIPO) (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)